Abu Dhabi Investment Authority (ADIA) is set to acquire a 3% stake in the Indian medical device company, Micro Life Sciences Pvt Ltd (Meril), for USD 200 million. This investment values Meril at USD 6.6 billion, pending regulatory approval from the Competition Commission of India (CCI). Meril plans to use the funds to accelerate growth and strengthen clinical research.
